Skip to content

Comparison of a lactose-free medical diet and a lactose-free formula in acute childhood diarrhea

Comparison of a lactose-free medical diet and a lactose-free formula in acute childhood diarrhea

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240706013
Enrollment
44
Registered
2024-07-06
Start date
2023-09-14
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute diarrhea in children. diarrhea, lactose-free medical formula, children

Interventions

Replace their old milk with investigated product as their usual practice. First phase: Admitted at the hospital not more than 14 day. Follow up phase: not more than 7 days.,Replace their old milk with
Lactose-free medical formula ,Lactose-free formula

Sponsors

Thai Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 24 Months

Inclusion criteria

Inclusion criteria: 1.Patients of both sexes who are at 6-24 months 2.Taking non lactose-free formula milk 3. Admitted at the hospital with watery diarrhea at least 1 time or diarrhea more than 3 times within 1 day but not more than 7 day 4.Obtain inform consent form his/her legal representative

Exclusion criteria

Exclusion criteria: 1. Taking lactose-free formula within 7 days previous enrollment. 2. Sepsis 3. Severe dehydration 4. Having history or diagnosed with Inflammatory bowel disease, necrotizing enterocolitis, intussusception, volvulus, celiac disease, immune deficiency, chronic disease that effect study outcome, advance cancer and terminal disease 6. Taking only breast milk 7. Not able to taking investigated product. 8. Taking prebiotic within 7 days previous enrollment. 9. Taking antibiotic within 7 days previous enrollment. 10. Taking smecta, hidrasec or dehecta within 7 days previous enrollment. 11. Having mucus bloody diarrhea 12. Allergic to cow's milk or components of study formula . 13. Taking other investigated product or stop taking not more than 30 days previous enrollment. 14. Having bacterial infection (except GI system) and taking antibiotic

Design outcomes

Primary

MeasureTime frame
Diarrheal symptoms (stool characteristics and frequency) Enrollment, discharge the hospital and follow up visit Observation

Secondary

MeasureTime frame
Body weight Enrollment, discharge the hospital and follow up visit Weighing,Gastrointestinal adverse event During the study Observation,quality of life of subject and their parent End of the study Questioniare,Cost of lactose-free formula in the study End of the study Calculation

Countries

Thailand

Contacts

Public ContactPannatorn Panyapalungkul

Thai Otsuka Pharmaceutical Co., Ltd.

pannatorn@thai-otsuka.co.th6624019560

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026